160
Views
52
CrossRef citations to date
0
Altmetric
Review

DNA methylation changes in prostate cancer: current developments and future clinical implementation

Pages 243-257 | Published online: 09 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Jin Wang, Xiao-Fan Yu, Nan OUYang, Qiulin Luo, Jian Tong, Tao Chen & Jianxiang Li. (2019) Role of DNA methylation regulation of miR-130b expression in human lung cancer using bioinformatics analysis. Journal of Toxicology and Environmental Health, Part A 82:17, pages 935-943.
Read now
Marie Korabecna, Eva Pazourkova, Ales Horinek, Magdalena Mokrejsova & Vladimir Tesar. (2012) Alterations in methylation status of immune response genes promoters in cell-free DNA during a hemodialysis procedure. Expert Opinion on Biological Therapy 12:sup1, pages S27-S33.
Read now
Mariana Brait & David Sidransky. (2011) Cancer epigenetics: above and beyond. Toxicology Mechanisms and Methods 21:4, pages 275-288.
Read now
Victor V Levenson. (2010) DNA methylation as a universal biomarker. Expert Review of Molecular Diagnostics 10:4, pages 481-488.
Read now

Articles from other publishers (48)

Shouyi Zhang, Tao Shen & Yu Zeng. (2023) Epigenetic Modifications in Prostate Cancer Metastasis and Microenvironment. Cancers 15:8, pages 2243.
Crossref
Jeremy Clark, Rachel Hurst, Mark Simon Winterbone, Hardeve Pahndha, Antoinnette Perry, Sophie McGrath, Richard Morgan, Adele E. Connor, Asia C Jordan, Deirdre Winrow & Colin Cooper. (2021) Urine Biomarkers for Prostate Cancer Diagnosis and Progression. Société Internationale d’Urologie Journal 2:3, pages 159-170.
Crossref
Ali Mehdi, David Cheishvili, Ani Arakelian, Tarek A. Bismar, Moshe Szyf & Shafaat A. Rabbani. (2020) DNA methylation signatures of Prostate Cancer in peripheral T-cells. BMC Cancer 20:1.
Crossref
Shixing Chen, Jing Su, Zhihan Zhao, Yuan Shao, Yanzhi Dou, Fuwu Li, Wangping Deng, Jiye Shi, Qian Li, Xiaolei Zuo, Shiping Song & Chunhai Fan. (2020) DNA Framework-Supported Electrochemical Analysis of DNA Methylation for Prostate Cancers. Nano Letters 20:10, pages 7028-7035.
Crossref
Prakash Chand Sharma & Kalyani Verma. 2020. Precision Medicine for Investigators, Practitioners and Providers. Precision Medicine for Investigators, Practitioners and Providers 167 178 .
Dunbar, Xu, Ryu, Ghosh, Shi & George. (2019) Detection of Differentially Methylated Regions Using Bayes Factor for Ordinal Group Responses. Genes 10:9, pages 721.
Crossref
Evgeny Izumchenko, Liat Shavit Grievink, Eli Rosenbaum & Mohammad Obaidul Hoque. (2019) GSTP1 as a Potential Marker of Early Chemotherapy Response for Noninvasive Detection. European Urology 76:3, pages 313-314.
Crossref
Yadong Xu, Qiong Song, Laura E. Pascal, Mingming Zhong, Yibin Zhou, Jianhua Zhou, Fang‐Ming Deng, Jiaoti Huang & Zhou Wang. (2019) DHX15 is up‐regulated in castration‐resistant prostate cancer and required for androgen receptor sensitivity to low DHT concentrations. The Prostate 79:6, pages 657-666.
Crossref
O. E. Bryzgunova, I. A. Zaporozhchenko, E. A. Lekchnov, E. V. Amelina, M. Yu. Konoshenko, S. V. Yarmoschuk, O. A. Pashkovskaya, A. A. Zheravin, S. V. Pak, E. Yu. Rykova & P. P. Laktionov. (2019) Data analysis algorithm for the development of extracellular miRNA-based diagnostic systems for prostate cancer. PLOS ONE 14:4, pages e0215003.
Crossref
Marianne Bjerre, Siri Strand, Maibritt Nørgaard, Helle Kristensen, Anne Rasmussen, Martin Mortensen, Jacob Fredsøe, Peter Mouritzen, Benedicte Ulhøi, Torben Ørntoft, Michael Borre & Karina Sørensen. (2019) Aberrant DOCK2, GRASP, HIF3A and PKFP Hypermethylation has Potential as a Prognostic Biomarker for Prostate Cancer. International Journal of Molecular Sciences 20:5, pages 1173.
Crossref
Alin Grelus, Dragos Nica, Imola Miklos, Valerica Belengeanu, Ioan Ioiart & Cristina Popescu. (2017) Clinical Significance of Measuring Global Hydroxymethylation of White Blood Cell DNA in Prostate Cancer: Comparison to PSA in a Pilot Exploratory Study. International Journal of Molecular Sciences 18:11, pages 2465.
Crossref
O. E. Bryzgunova & P. P. Laktionov. (2017) Current methods of extracellular DNA methylation analysis. Molecular Biology 51:2, pages 167-183.
Crossref
Xiaoming Gong, Raju Marisiddaiah, Susan Zaripheh, Doris Wiener & Lewis P. Rubin. (2016) Mitochondrial β-Carotene 9′,10′ Oxygenase Modulates Prostate Cancer Growth via NF-κB Inhibition: A Lycopene-Independent Function. Molecular Cancer Research 14:10, pages 966-975.
Crossref
Inessa Skrypkina, Liudmyla Tsyba, Kateryna Onyshchenko, Dmytro Morderer, Olena Kashparova, Oleksii Nikolaienko, Grigory Panasenko, Sergii Vozianov, Alina Romanenko & Alla Rynditch. (2016) Concentration and Methylation of Cell-Free DNA from Blood Plasma as Diagnostic Markers of Renal Cancer. Disease Markers 2016, pages 1-10.
Crossref
Georgios Theophilou, Kássio M. G. Lima, Matthew Briggs, Pierre L. Martin-Hirsch, Helen F. Stringfellow & Francis L. Martin. (2015) A biospectroscopic analysis of human prostate tissue obtained from different time periods points to a trans-generational alteration in spectral phenotype. Scientific Reports 5:1.
Crossref
Alessandra CastegnaVito Iacobazzi & Vittoria Infantino. (2015) The mitochondrial side of epigenetics. Physiological Genomics 47:8, pages 299-307.
Crossref
O.E. Bryzgunova & P.P. Laktionov. (2015) Generation of blood circulating DNA: the sources, peculiarities of circulation and structure. Biomeditsinskaya Khimiya 61:4, pages 409-426.
Crossref
I M Reis, K Ramachandran, C Speer, E Gordian & R Singal. (2015) Serum GADD45a methylation is a useful biomarker to distinguish benign vs malignant prostate disease. British Journal of Cancer 113:3, pages 460-468.
Crossref
Lian Zhang, Qian Zhang, LiLi Li, Zhaohui Wang, Jianming Ying, Yu Fan, Qun He, Tianjing LV, Wenke Han, Jun Li, Yang Yang, Ben Xu, Lu Wang, Qianling Liu, Yinghao Sun, Yinglu Guo, Qian Tao & Jie Jin. (2015) DLEC1, a 3p tumor suppressor, represses NF-κB signaling and is methylated in prostate cancer. Journal of Molecular Medicine 93:6, pages 691-701.
Crossref
Jiling Wen, Rongbing Li, Xiaofei Wen, Guangming Chou, Jiasun Lu, Xuelei Wang & Yongchao Jin. (2014) RETRACTED ARTICLE: Dysregulation of cell cycle related genes and microRNAs distinguish the low- from high-risk of prostate cancer. Diagnostic Pathology 9:1.
Crossref
O. E. Bryzgunova & P. P. Laktionov. (2014) Generation of blood circulating DNAs: Sources, features of struction and circulation. Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry 8:3, pages 203-219.
Crossref
Joo Mi Yi, Angela A. Guzzetta, Vasudev J. Bailey, Stephanie R. Downing, Leander Van Neste, Katherine B. Chiappinelli, Brian P. Keeley, Alejandro Stark, Alexander Herrera, Christopher Wolfgang, Emmanouil P. Pappou, Christine A. Iacobuzio-Donahue, Michael G. Goggins, James G. Herman, Tza-Huei Wang, Stephen B. Baylin & Nita Ahuja. (2013) Novel Methylation Biomarker Panel for the Early Detection of Pancreatic Cancer. Clinical Cancer Research 19:23, pages 6544-6555.
Crossref
Ata AbbasWilliam PattersonIIIIIIPhilippe T. Georgel. (2013) The epigenetic potentials of dietary polyphenols in prostate cancer management. Biochemistry and Cell Biology 91:6, pages 361-368.
Crossref
Vito Iacobazzi, Alessandra Castegna, Vittoria Infantino & Generoso Andria. (2013) Mitochondrial DNA methylation as a next-generation biomarker and diagnostic tool. Molecular Genetics and Metabolism 110:1-2, pages 25-34.
Crossref
Deliang Tang, Oleksandr N. Kryvenko, Nicoleta Mitrache, Kieu C. Do, Michelle Jankowski, Dhananjay A. Chitale, Sheri Trudeau, Andrew Rundle, Steven A. Belinsky & Benjamin A. Rybicki. (2013) Methylation of the RARB Gene Increases Prostate Cancer Risk in Black Americans . Journal of Urology 190:1, pages 317-324.
Crossref
Hyung-Yoon YoonYoung-Won KimHo Won KangWon Tae KimSeok-Joong Yun, Sang-Cheol LeeWun-Jae KimYong-June Kim. (2013) Pyrosequencing Analysis of APC Methylation Level in Human Prostate Tissues: A Molecular Marker for Prostate Cancer . Korean Journal of Urology 54:3, pages 194.
Crossref
Benjamin A. Rybicki. 2013. Epigenetics and Cancer. Epigenetics and Cancer 151 166 .
Hyung-Yoon Yoon, Seon-Kyu Kim, Young-Won Kim, Ho Won Kang, Sang-Cheol Lee, Keun Ho Ryu, Ho Sun Shon, Wun-Jae Kim & Yong-June Kim. (2012) Combined Hypermethylation of APC and GSTP1 as a Molecular Marker for Prostate Cancer: Quantitative Pyrosequencing Analysis. SLAS Discovery 17:7, pages 987-992.
Crossref
Anna Vinarskaja, Wolfgang Goering, Marc Ingenwerth & Wolfgang A. Schulz. (2011) ID4 is frequently downregulated and partially hypermethylated in prostate cancer. World Journal of Urology 30:3, pages 319-325.
Crossref
Teodora Ribarska, Klaus-Marius Bastian, Annemarie Koch & Wolfgang A Schulz. (2012) Specific changes in the expression of imprinted genes in prostate cancer—implications for cancer progression and epigenetic regulation. Asian Journal of Andrology 14:3, pages 436-450.
Crossref
Lissette Delgado-CruzataGregory W. HrubyKarina GonzalezJames McKiernanMitchel C. BensonRegina M. SantellaJing Shen. (2012) DNA Methylation Changes Correlate with Gleason Score and Tumor Stage in Prostate Cancer. DNA and Cell Biology 31:2, pages 187-192.
Crossref
Hyung-Yoon YoonYoung-Won KimHo-Won KangWon Tae KimSeok-Joong Yun, Sang-Cheol LeeWun-Jae KimYong-June Kim. (2012) DNA Methylation of GSTP1 in Human Prostate Tissues: Pyrosequencing Analysis . Korean Journal of Urology 53:3, pages 200.
Crossref
Wun-Jae Kim & Yong-June Kim. 2012. Cancer Epigenetics. Cancer Epigenetics 111 118 .
Christian Arsov, Wolfgang Goering & Wolfgang A. Schulz. 2012. Patho-Epigenetics of Disease. Patho-Epigenetics of Disease 123 157 .
Jeffrey R Shuster, Raymond S Lance & Dean A Troyer. (2011) Molecular preservation by extraction and fixation, mPREF: a method for small molecule biomarker analysis and histology on exactly the same tissue. BMC Clinical Pathology 11:1.
Crossref
B Verdoodt, F Sommerer, R-J Palisaar, J Noldus, M Vogt, S Nambiar, A Tannapfel, A Mirmohammadsadegh & M Neid. (2011) Inverse association of p16INK4a and p14ARF methylation of the CDKN2a locus in different Gleason scores of prostate cancer. Prostate Cancer and Prostatic Diseases 14:4, pages 295-301.
Crossref
A. Ameri, A. Alidoosti, Y. Hosseini, M. Parvin, M. H. Emranpour, F. Taslimi, E. Salehi & P. Fadavi. (2011) Prognostic value of promoter hypermethylation of Retinoic Acid Receptor Beta (RARB) and CDKN2 (p16/MTS1) in prostate cancer. Chinese Journal of Cancer Research 23:4, pages 306-311.
Crossref
Anna Vinarskaja, Masanori Yamanaka, Marc Ingenwerth & Wolfgang A. Schulz. (2011) DNA Methylation and the HOXC6 Paradox in Prostate Cancer. Cancers 3:4, pages 3714-3725.
Crossref
E S Antonarakis & A J Armstrong. (2011) Emerging therapeutic approaches in the management of metastatic castration-resistant prostate cancer. Prostate Cancer and Prostatic Diseases 14:3, pages 206-218.
Crossref
Yong-June Kim, Hyung-Yoon Yoon, Seon-Kyu Kim, Young-Won Kim, Eun-Jung Kim, Isaac Yi Kim & Wun-Jae Kim. (2011) EFEMP1 as a Novel DNA Methylation Marker for Prostate Cancer: Array-Based DNA Methylation and Expression Profiling . Clinical Cancer Research 17:13, pages 4523-4530.
Crossref
Weiwei Liu, Jian Gong, Jinghui Hu, Tingting Hu, Yaofei Sun, Junhua Du, Chuanyu Sun, Ming Guan, Haowen Jiang & Yuan Lu. (2011) Quantitative Assessment of AKAP12 Promoter Methylation in Human Prostate Cancer Using Methylation-sensitive High-resolution Melting: Correlation With Gleason Score. Urology 77:4, pages 1006.e1-1006.e7.
Crossref
Costantine Albany, Ajjai S. Alva, Ana M. Aparicio, Rakesh Singal, Sarvari Yellapragada, Guru Sonpavde & Noah M. Hahn. (2011) Epigenetics in Prostate Cancer. Prostate Cancer 2011, pages 1-12.
Crossref
Emmanuel S. Antonarakis & Michael A. Carducci. (2010) Future Directions in Castrate-Resistant Prostate Cancer Therapy. Clinical Genitourinary Cancer 8:1, pages 37-46.
Crossref
. (2010) Current World Literature. Current Opinion in Supportive & Palliative Care 4:3, pages 207-227.
Crossref
M. Colombel, E. Ricci, A. Picard & E. Bourrelly. (2010) Hyperméthylation et cancer de la prostate. Progrès en Urologie 20:6, pages 408-415.
Crossref
Emmanuel S. Antonarakis, Michael A. Carducci & Mario A. Eisenberger. (2010) Novel targeted therapeutics for metastatic castration-resistant prostate cancer. Cancer Letters 291:1, pages 1-13.
Crossref
Hafiz Ahmed. (2010) Promoter Methylation in Prostate Cancer and its Application for the Early Detection of Prostate Cancer Using Serum and Urine Samples. Biomarkers in Cancer 2, pages BIC.S3187.
Crossref
Christoph Kneip, Bernd Schmidt, Michael Fleischhacker, Anke Seegebarth, Jörn Lewin, Nadja Flemming, Stefanie Seemann, Thomas Schlegel, Christian Witt, Volker Liebenberg & Dimo Dietrich. (2009) A novel method for sensitive and specific detection of DNA methylation biomarkers based on DNA restriction during PCR cycling. BioTechniques 47:3, pages 737-744.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.